| Title： | 2022 Guidelines for Preventive Treatment of Tuberculosis in China |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | This guideline applies to all levels of medical institutions. This guideline is intended for use by TB physicians, infectious disease physicians, rheumatologists, transplant physicians, hemodialysis physicians, and healthcare professionals associated with the diagnosis and management of LTBI. |
| Evidence classification method： | GRADE method of grading evidence |
| Development unit： | Tuberculosis Branch of Chinese Medical Association; National Clinical Research Center for Infectious Diseases; Shenzhen Third People's Hospital |
| Registration time: | 2022-05-08 |
| Registration number： | IPGRP-2022CN256 |
| Purpose of the guideline: | Establish the prevention, intervention and management of latent tuberculosis infection in China, in order to guide clinicians and relevant nursing staff to promote the control and management of latent tuberculosis infection in China. |
